Cargando…
THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
OBJECTIVE: Coronavirus disease 2019 is an infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical and laboratory predictors may identification of patients at risk of mortality and guide treatment .To analyze laboratory abnormalities in patients w...
Autores principales: | YILMAZ, Fatma, ALBAYRAK, Murat, YILDIZ, Abdülkerim, AFACAN ÖZTÜRK, Hacer Berna, MARAL, Senem, MALKAN, Ümit Yavuz, AKYOL, Pınar, REİS ARAS, Merih, SAĞLAM, Buğra, TIĞLIOĞLU, Mesut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Editora Ltda.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572574/ http://dx.doi.org/10.1016/j.htct.2021.10.979 |
Ejemplares similares
-
The outcome of COVID-19 in patients with hematological malignancy
por: Tığlıoğlu, Pınar, et al.
Publicado: (2021) -
DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
por: YILMAZ, Fatma, et al.
Publicado: (2021) -
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
por: YILMAZ, Fatma, et al.
Publicado: (2021) -
CORONAVIRUS ANXIETY LEVEL AND COVID 19 VACCINE ATTITUDE AMONG HEMATOLOGICAL MALIGNANCY PATIENTS
por: GÜVEN, Zeynep Tuğba, et al.
Publicado: (2022) -
A rare case of pulmonary lymphomatoid granulomatosis complicated with venous thrombosis
por: Maral, Senem, et al.
Publicado: (2021)